Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
基本信息
- 批准号:9093834
- 负责人:
- 金额:$ 49.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-26 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AMPA ReceptorsActininAcuteAffectAlzheimer&aposs DiseaseAutistic DisorderBindingCalmodulinCentral Nervous System DiseasesChemicalsCo-ImmunoprecipitationsComplexDLG4 geneDataEngineeringEpilepsyExhibitsF-ActinFluorescence MicroscopyFoundationsFrequenciesFunctional disorderGlutamate ReceptorHealthHippocampus (Brain)Homologous GeneInjection of therapeutic agentLinkMaintenanceMediatingMental DepressionMolecularMonitorMutateMutationN-MethylaspartateN-terminalNeuronsPeptidesPhenocopyPhysiologicalPoint MutationPost-Traumatic Stress DisordersProcessProteinsPsyche structureRoleSchizophreniaSiteStrokeStructureSynapsesSynaptic TransmissionTestingTranslatingVertebral columnWorkalpha Actininknock-downmutantnervous system disorderoverexpressionpostsynapticprenylationprevent
项目摘要
DESCRIPTION (provided by applicant): AMPAR and spine dysfunction or dysregulation underlies many CNS diseases including depression, autism, PTSD, epilepsy, and stroke-induced neuronal damage. Precise postsynaptic localization of AMPARs is critical for fast synaptic transmission. It depends on PSD-95 and its interaction with auxiliary AMPAR subunits called TARPs. Despite its central role in targeting AMPARs, it is unknown how PSD-95 itself is anchored at the postsynapse. Our preliminary data suggest that A) a-actinin binds to the first 13 residues of the N-terminus of PSD-95; B) knock-down (KD) of a-actinin reduces postsynaptic PSD-95 content and mEPSCs, the latter phenocopying KD of PSD-95; C) mutating either Lys10 or Lys11 to Glu (K10E, K11E) specifically impairs PSD- 95 binding to a-actinin and postsynaptic targeting of PSD-95 and of AMPARs; D) peptide PSD95(1-13) displaces PSD-95 from a-actinin; E) injection of PSD95(1-13) decreases mEPSC amplitude. We hypothesize that a-actinin is critical for postsynaptic anchoring of PSD-95 and thereby AMPAR-TARP complexes. Proving this hypothesis will fundamentally advance our understanding of postsynaptic AMPAR localization. A), B), and D) are final data. Aims 1 and 2 will further scrutinize C) and E), i.e., whether mutating K10E and K11E or injecting PSD95(1-13) affect synaptic PSD-95 and AMPAR taregting using fluorescence microscopy and mEPSC. NMR structural analysis will identify residues in a-actinin that are important for PSD-95 binding. KD of endogenous a-actinin and replacement with either WT or mutant a-actinin will show whether mutant a-actinin is not able to rescue the KD effect on PSD-95, in contrast to our rescue with WT a-actinin. Aim 3 is to test whether NMDA-induced Ca2+ influx displaces PSD-95 from a-actinin and thereby from postsynaptic sites along with AMPARs via calmodulin (CaM). We found that Ca2+/CaM binds to the N-terminus of PSD-95 to dislodge a-actinin. Our structural NMR analysis of a complex between Ca2+/CaM and the first 71 aa of PSD-95 identified Y12 in PSD-95 as critical for CaM binding. Mutating Y12 to Glu (Y12E) prevents Ca2+/CaM binding without affecting a-actinin binding or postsynaptic localization of PSD-95. NMDA-induced Ca2+ influx displaces a portion of WT but not Y12E PSD-95 from spines. In fact, Y12E exhibits a large increase rather than decrease in spines upon Ca2+ influx. We will test whether this mutation and other manipulations unmask a mechanism that leads to postsynaptic accumulation of PSD-95 and AMPARs rather than their decrease. Such a decrease is usually seen following 5 min NMDA treatment and is referred to as chemical LTD. This exciting new direction will elucidate how Ca2+ influx can cause LTD rather than LTP. Page 1
描述(由申请人提供):AMPAR和脊柱功能障碍或失调是许多CNS疾病的基础,包括抑郁症、自闭症、PTSD、癫痫和中风诱导的神经元损伤。AMPAR的精确突触后定位对于快速突触传递至关重要。它依赖于PSD-95及其与称为TARP的辅助AMPAR亚基的相互作用。尽管PSD-95在靶向AMPAR中起着核心作用,但目前尚不清楚PSD-95本身如何锚定在突触后。我们的初步研究结果表明:A)α-辅肌动蛋白与PSD-95 N端的前13个残基结合,B)α-辅肌动蛋白的敲低(KD)降低了突触后PSD-95含量和mEPSC,后者表型复制PSD-95的KD; C)将Lys 10或Lys 11突变为Glu(K10 E,K11 E)特异性地损害PSD-95与α-辅肌动蛋白的结合以及PSD-95和AMPAR的突触后靶向; E)注射PSD 95(1-13)降低mEPSC振幅。我们假设α-辅肌动蛋白对于PSD-95的突触后锚定以及AMPAR-TARP复合物是至关重要的。证明这一假设将从根本上推进我们对突触后AMPAR定位的理解。A)、B)和D)为最终数据。目标1和2将进一步审查C)和E),即,无论是突变K10 E和K11 E还是注射PSD 95(1-13),使用荧光显微镜和mEPSC影响突触PSD-95和AMPAR taregting。NMR结构分析将鉴定α-辅肌动蛋白中对PSD-95结合重要的残基。内源性α-辅肌动蛋白的KD和用WT或突变体α-辅肌动蛋白替换将显示突变体α-辅肌动蛋白是否不能拯救对PSD-95的KD作用,与我们用WT α-辅肌动蛋白的拯救相反。目的3是测试NMDA诱导的Ca 2+内流是否从α-辅肌动蛋白中置换PSD-95,从而通过钙调蛋白(CaM)与AMPAR沿着从突触后位点置换PSD-95。我们发现,Ca ~(2+)/CaM结合PSD-95的N-末端,以驱逐α-辅肌动蛋白。我们对Ca 2 +/CaM和PSD-95的前71个氨基酸之间的复合物的结构NMR分析确定PSD-95中的Y12对CaM结合至关重要。将Y12突变为Glu(Y12 E)阻止Ca 2 +/CaM结合,而不影响PSD-95的α-辅肌动蛋白结合或突触后定位。NMDA诱导的Ca 2+内流从棘置换WT的一部分,但不置换Y12 E PSD-95。事实上,Y12 E在Ca 2+内流时表现出刺的大量增加而不是减少。我们将测试这种突变和其他操作是否揭示了导致PSD-95和AMPAR突触后积累而不是减少的机制。这样的减少通常是看到5分钟NMDA治疗后,被称为化学LTD。这一令人兴奋的新方向将阐明如何Ca 2+流入可能会导致LTD,而不是LTP。第1页
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHANNES W HELL其他文献
JOHANNES W HELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHANNES W HELL', 18)}}的其他基金
Postsynaptic Signaling by Norepinephrine and cAMP
去甲肾上腺素和 cAMP 的突触后信号传导
- 批准号:
10445917 - 财政年份:2022
- 资助金额:
$ 49.44万 - 项目类别:
Postsynaptic Signaling by Norepinephrine and cAMP
去甲肾上腺素和 cAMP 的突触后信号传导
- 批准号:
10557151 - 财政年份:2022
- 资助金额:
$ 49.44万 - 项目类别:
Detection of Synaptic Proteins with Fluorescent Molecular Rotor-labeled Peptides
使用荧光分子转子标记肽检测突触蛋白
- 批准号:
10063961 - 财政年份:2019
- 资助金额:
$ 49.44万 - 项目类别:
Dysregulation of Cav1.2 by beta amyloid peptide
β 淀粉样肽导致 Cav1.2 失调
- 批准号:
10521735 - 财政年份:2016
- 资助金额:
$ 49.44万 - 项目类别:
Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
- 批准号:
8935917 - 财政年份:2014
- 资助金额:
$ 49.44万 - 项目类别:
Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
- 批准号:
8818208 - 财政年份:2014
- 资助金额:
$ 49.44万 - 项目类别:
Signaling by cAMP within Postsynaptic Nanodomains
突触后纳米结构域内的 cAMP 信号传导
- 批准号:
8439852 - 财政年份:2012
- 资助金额:
$ 49.44万 - 项目类别:
Signaling by cAMP within postsynaptic nano domains R01NS078792
突触后纳米域内 cAMP 的信号传导 R01NS078792
- 批准号:
9066462 - 财政年份:2012
- 资助金额:
$ 49.44万 - 项目类别:
相似国自然基金
肌动蛋白交联蛋白α-actinin在子宫内膜容受态建立中的作用及调控机制
- 批准号:81671517
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
TGF-β1/SMAD2/α-actinin-2/Kv1.5通路在房颤心房电重构中的作用及机制研究
- 批准号:81300140
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
NHERF1调节α-actinin 4的表达对细胞微丝骨架及宫颈癌细胞转移的影响
- 批准号:81272887
- 批准年份:2012
- 资助金额:65.0 万元
- 项目类别:面上项目
α-actinin 4介导NHERF1调节细胞微丝骨架及其对肿瘤细胞黏附与迁移的影响
- 批准号:81141033
- 批准年份:2011
- 资助金额:10.0 万元
- 项目类别:专项基金项目
Ca2+-CaM信号系统与丝状真菌中人辅肌动蛋白alpha-actinin同源基因对极性生长调控的分子机理
- 批准号:30770031
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Understanding the role of alpha-actinin in cardiac disease: from molecules to mice
了解 α-肌动蛋白在心脏病中的作用:从分子到小鼠
- 批准号:
2734442 - 财政年份:2022
- 资助金额:
$ 49.44万 - 项目类别:
Studentship
The effect of α-actinin 3 deficiency on regulation of skeletal muscle mass in health and disease.
α-肌动蛋白 3 缺乏症对健康和疾病中骨骼肌质量调节的影响。
- 批准号:
nhmrc : GNT1114935 - 财政年份:2016
- 资助金额:
$ 49.44万 - 项目类别:
Postgraduate Scholarships
Alpha-actinin-4 as an oncogenic driver and therapeutic target in melanoma
Alpha-actinin-4 作为黑色素瘤的致癌驱动因素和治疗靶点
- 批准号:
nhmrc : GNT1099947 - 财政年份:2016
- 资助金额:
$ 49.44万 - 项目类别:
Project Grants
The effect of ?-actinin 3 deficiency on regulation of skeletal muscle mass in health and disease.
β-肌动蛋白 3 缺乏症对健康和疾病中骨骼肌质量调节的影响。
- 批准号:
nhmrc : 1114935 - 财政年份:2016
- 资助金额:
$ 49.44万 - 项目类别:
Postgraduate Scholarships
Alpha-actinin-4 as an oncogenic driver and therapeutic target in melanoma
Alpha-actinin-4 作为黑色素瘤的致癌驱动因素和治疗靶点
- 批准号:
nhmrc : 1099947 - 财政年份:2016
- 资助金额:
$ 49.44万 - 项目类别:
Project Grants
Production of full length alpha-actinin-3 protein from ACTN3 gene X genotype
从 ACTN3 基因 X 基因型生产全长 α-actinin-3 蛋白
- 批准号:
16K13015 - 财政年份:2016
- 资助金额:
$ 49.44万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Discovering The Effect of alpha-actinin-3 Deficiency on Muscle Adaptations to Exercise Training in Humans
发现 α-actinin-3 缺乏对人类运动训练肌肉适应的影响
- 批准号:
DE140100864 - 财政年份:2014
- 资助金额:
$ 49.44万 - 项目类别:
Discovery Early Career Researcher Award
The effects of ?-actinin-3 on muscle metabolism, human health and disease
β-actinin-3 对肌肉代谢、人类健康和疾病的影响
- 批准号:
nhmrc : 1062500 - 财政年份:2014
- 资助金额:
$ 49.44万 - 项目类别:
Project Grants